This finding is consistent with published data showing that cell-mediated immunity, including CD8 T cell function, is markedly compromised in CTCL patients23–25 as well as patients with other T cell malignancies26,27. Here, CD8A is linked to primary cutaneous T-cell non-Hodgkin lymphoma.